Busulfan Injection, Solution
Product Images NDC 0409-1112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Busulfan (NDC 0409-1112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Busulfan 01)

Chemical Structure (Busulfan 01)
Chemical structure of Busulfan showing its molecular arrangement with two sulfonate groups connected by a four-carbon chain, corresponding to the active ingredient in the injection solution.*
FDA Label Image

Logo (Busulfan 02)

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Label for Busulfan Injection 60 mg/10 mL (6 mg/mL) intravenous infusion solution, a sterile single-dose vial. Manufactured by Gland Pharma Limited, India, for Hospira, Inc., Lake Forest, IL. Contains 60 mg busulfan per vial with dimethylacetamide and polyethylene glycol-400. Includes storage instructions and caution for dilution before use.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
Busulfan Injection 60 mg/10 mL (6 mg/mL) carton label for intravenous infusion. The label states it is a sterile single-dose vial and a cytotoxic agent. Manufactured by Gland Pharma Limited, India, for Hospira, Inc. Includes storage instructions, dosage components, and a barcode. The label warns the solution must be diluted before use.*
FDA Label Image

Principal Display Panel (8 Vial Carton)

Principal Display Panel (8 Vial Carton)
Busulfan Injection 60 mg/10 mL (6 mg/mL) packaging label for eight 10 mL single-dose vials. The label specifies that the product is sterile and for intravenous infusion only, with a caution to dilute before use. It is a cytotoxic agent labeled by Hospira, Inc., manufactured by Gland Pharma Limited, India, and made for Hospira, Inc. in Lake Forest, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.